<DOC>
	<DOCNO>NCT01404676</DOCNO>
	<brief_summary>The effect vildagliptin base treatment versus sulfonylurea base treatment glycemic variability , oxidative stress , endothelial function patient type 2 diabetes .</brief_summary>
	<brief_title>The Effect Vildagliptin Based Treatment Versus Sulfonylurea Glycemic Variability , Oxidative Stress , GLP-1 , Endothelial Function Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Recently , improve understanding incretin effect pathophysiology type 2 diabetes lead development new agent hypoglycemic therapy . Vildagliptin potent highly selective dipeptidyl peptidase-4 ( DPP-4 ) inhibitor augments active glucagon-like peptide ( GLP ) -1 concentration , increase insulin secretion improve glucose tolerance . Vildagliptin similar glucose lower effect , low hypoglycemic event , compare glimepiride . Vildagliptin could improve mean glycemic control also 24 hour glycemic fluctuation restore physiologic pattern insulin glucagon secretion . Furthermore , decrease postprandial glycemic excursion might reduce oxidative stress marker improve endothelial dysfunction . Those effect might amplify Asian patient prominent early phase insulin secretory defect accompany relatively less degree insulin resistance . In addition , GLP-1 GLP-1 analogue exert direct beneficial effect endothelium-dependent vasodilatation . Therefore DPP-4 inhibitor may directly improve endothelial dysfunction . Based assumption , research focus effect vildagliptin glycemic variability , oxidative stress marker endothelial cell function compare long act sulfonylurea glimepiride type 2 diabetic patient inadequate glycemic control metformin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetic patient A1C level within range 7 % 10 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Glucose variability</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Endothelial cell function</keyword>
</DOC>